Form 4: Procept BioRobotics Director Antal Rohit Desai Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Director Antal Rohit Desai of Procept BioRobotics Corp. sold shares of common stock between September 10 and September 12, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Antal Rohit Desai, a director of Procept BioRobotics Corp, reported the sale of common stock between September 10 and September 12, 2024.
- The sales were executed under a Rule 10b5-1 trading plan adopted on May 30, 2024.
- The shares were sold at weighted average prices ranging from $75.7813 to $80.6477.
- The sales resulted in a decrease in the number of shares indirectly beneficially owned by Desai through The 2:22 DNA Trust.
- The total number of shares held by The 2:22 DNA Trust after all transactions is 197,453.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of stock sales under a pre-arranged trading plan. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This filing is a routine disclosure of insider trading activity. It is common for corporate insiders to utilize 10b5-1 trading plans to sell shares over time to avoid accusations of trading on material non-public information.
Stakeholder Impact
- The stock sales by a director could create short-term selling pressure on the stock.
- The sales are unlikely to have a significant long-term impact on the company's operations or financial performance.
Key Dates
| Date | Description |
|---|---|
| May 30, 2024 | Date of adoption of the Rule 10b5-1 Trading Plan |
| 09/10/2024 | First transaction date: sale of 18,690 shares at $75.7813 and 17,810 shares at $76.5984 |
| 09/11/2024 | Second transaction date: sale of 8,904 shares at $75.9037, 4,880 shares at $77.0896, 20,732 shares at $78.1207 and 4,182 shares at $78.6718 |
| 09/12/2024 | Third transaction date: sale of 4,458 shares at $77.9953, 2,318 shares at $78.8939, 9,402 shares at $79.7805 and 28,689 shares at $80.6477 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.